Prolia denied as not medically necessary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for prolia are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies Prolia on Medical-Necessity Grounds

UnitedHealthcare requires prior authorization for Prolia (denosumab) and applies detailed coverage criteria before approving it. Medical-necessity denials typically arise because the submitted documentation does not demonstrate that the patient has met UHC's step-therapy requirements (prior use of other agents), that the diagnosis has been confirmed with appropriate clinical workup, or that the prescriber has addressed UHC's specific clinical thresholds. Because UHC's criteria are specific and the PA process is documentation-intensive, incomplete submissions are a frequent cause of denial even when the clinical case is strong.

## Why This Denial Is Appealable

Medical-necessity determinations must be based on the individual patient's clinical record, not on a checklist applied without review of the actual chart. If the prescriber has confirmed the diagnosis, documented the clinical severity and history, and addressed UHC's criteria — even if that documentation was not included in the initial submission — the denial should be appealed with a complete record. UHC's internal criteria must themselves be consistent with the standard of care as defined by relevant professional bodies such as the American Society for Bone and Mineral Research; a denial that misapplies those criteria is reviewable.

## Federal Appeal Framework

• Internal appeal (ACA §2719): At least one internal appeal is guaranteed. Request the specific UHC coverage policy for Prolia (by name and version) and the exact criteria cited as unmet in the denial.
• ERISA §503: For employer-sponsored plans, ERISA entitles you to the full claims file, the specific criteria applied, and the clinical reviewer's qualifications.
• External review: After exhausting internal appeals, ACA §2719 external review by an independent organization is available. Independent reviewers apply clinical-evidence standards rather than UHC's internal criteria alone, and medical-necessity denials for FDA-approved therapies are frequently reversed when the clinical record is complete.
• Timeline: External review requests are typically due within four months of the final adverse internal decision. Expedited review (72-hour decision) is available when delay seriously jeopardizes health or ability to regain maximum function.

## Documents to Gather

• Diagnosis confirmation: Bone density testing results, relevant laboratory workup, and the treating clinician's documented diagnosis, consistent with the applicable guideline organization's (e.g., ASBMR, NOF) diagnostic criteria.
• Prior-treatment history: Documentation of all prior osteoporosis or bone-modifying therapies, including agent names, duration of use, dates started and stopped, and the clinical outcome or reason for discontinuation.
• Clinical severity documentation: Chart notes reflecting the prescriber's assessment of fracture risk and clinical severity, as characterized under the applicable guideline organization's framework.
• Prescriber medical-necessity letter: A comprehensive letter addressing each of UHC's coverage criteria for Prolia by name, with specific chart citations supporting each criterion.
• UHC Prolia coverage policy: Obtain UHC's current published policy document (available through UHC's provider portal or on request). Confirm the version used in your denial and verify you are appealing under the current criteria.

## Criteria-Mapping Structure

Build a table with one row per UHC coverage criterion. Left column: exact policy language. Right column: specific chart entry, test result, or letter paragraph satisfying that criterion. Submit this table as an exhibit to your appeal letter. This format compels the reviewer to address each criterion individually and prevents a repeat generalized denial.